Approvals/TGA/MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 40 mg / 2 mL injection vial

Approved

STANDARD

MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 40 mg / 2 mL injection vial

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 414e2a37b0732c7d
Product Name: MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 40 mg / 2 mL injection vial
Artg Id: 167203
Artg Name: MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 40 mg / 2 mL injection vial
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2010-10-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/13adbd182139d99eb17c79b4ea2abde3.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d8abeedf1c8214f70e8a0d4cc73f6ad0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

414e2a37b0732c7d

Type

Standard